AUSTIN, Texas, Aug. 7, 2013 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation (PSID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/8-6-13-smallcapvoice-interview-with-positiveid-corporation-psid.
William J. Caragol, Chairman and CEO of PositiveID, stated, “The significant, patented technology advances we have achieved throughout the years of development of our M-BAND system, will be represented in a miniaturized format in our handheld Firefly device, which will be used for the identification of biological agents associated with weapons of mass destruction, as well as point-of-need monitoring of pathogenic outbreaks and agricultural screening. Firefly is being designed as a portable, point-of-need molecular diagnostic system to provide test results from sample input through reporting of results in 15 to 30 minutes depending on the type of test performed, providing first-of-its-kind rapid biological detection.”
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID’s future expectations, including, without limitation, the likelihood that the significant, patented technology advances PositiveID has achieved throughout the years of development of its M-BAND system, will be represented in a miniaturized format in its handheld Firefly device, which will be used for the identification of biological agents associated with weapons of mass destruction, as well as point-of-need monitoring of pathogenic outbreaks and agricultural screening; the likelihood that Firefly is being designed as a portable, point-of-need molecular diagnostic system to provide test results from sample input through reporting of results in 15 to 30 minutes depending on the type of test performed, providing first-of-its-kind biological detection; and all statements in the interview between SmallCapVoice.com and PositiveID constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the biological detection and diagnostic sectors; the Company’s ability to attract the research and development capital to complete the development of Firefly; as well as other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 16, 2013 under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.